proteome profiler human cytokine array kit (R&D Systems)
Structured Review

Proteome Profiler Human Cytokine Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 548 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cytokines/Proteome+Profiler+Human+Cytokine+Array+Kit/pmc12996814-57-0-9
Average 96 stars, based on 548 article reviews
Images
1) Product Images from "Prophylactic C-terminal occludin–derived peptide attenuates LPS-induced airway inflammation via barrier preservation and mitochondrial ROS regulation"
Article Title: Prophylactic C-terminal occludin–derived peptide attenuates LPS-induced airway inflammation via barrier preservation and mitochondrial ROS regulation
Journal: Redox Biology
doi: 10.1016/j.redox.2026.104119
Figure Legend Snippet: Occludin modulates LPS-induced IL-8 secretion, barrier integrity, and cytoskeletal remodeling in human bronchial epithelial cells. (A) The BEAS-2b cells were transfected and were then incubated with LPS in a time-dependent manner before the generation of total cell lysates, and occludin transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared to the control. (B) The cells were treated with LPS in a time-dependent manner. The occludin-specific antibody was assessed by Western blot analysis. β-actin was used as a loading control. (C) A construct expressing wild-type occludin or siRNA-occludin was transiently transfected into BEAS-2b cells. The cells were washed and serum-starved overnight. They were subsequently treated with LPS for 2 h and a cytokine assay was performed with cultured media and cell lysates were harvested for qRT-PCR of IL-8 (D) . The density of the resulting spots of IL-8 was measured using a densitometric analysis. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. (E) The cells were transfected with either the wild-type occludin construct or siRNA-occuldin before incubation with LPS for various times, and then TEER testing was performed. Error bars represent the SEM of at least three independent experiments. (F) Cells were then treated with LPS for 2 h. F-actin staining was performed using ActinRed 555 ReadyProbe reagent (Molecular Probes) following the manufacturer's instructions. Cell nuclei were stained with diluted Deep Red (1:300). The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. All data are representative of at least three independent experiments.
Techniques Used: Transfection, Incubation, Quantitative RT-PCR, Control, Western Blot, Construct, Expressing, Cytokine Assay, Cell Culture, Staining, Fluorescence
Figure Legend Snippet: The peptide regulates mitochondrial dysfunction and ROS production by inhibiting LPS-induced p38 activation. (A) The BEAS-2b cells were treated with wild-type occludin peptide (pepWT OCLN) or mutant occludin peptide (pepMut OCLN) and incubated with LPS for 15, 30 min. The phospho-specific and total antibodies were assessed by Western blot analysis. β-actin was used as a loading control. (B) The BEAS-2b cells were transfected with p38 overexpression construct (WT p38) or siRNA-p38 for 24 h and incubated with LPS for 4 h siRNA-scramble was used as a negative control. The proinflammatory cytokine transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT p38-transfected cells. (C) The mitochondrial membrane potential of LPS-induced BEAS-2b cells treated with either WT OCLN peptide or mut peptide was stained with JC-1 dye. Images are representative results of 3 independent experiments. (D) The mitochondria fission was stained using phospho-Drp1 antibody and visualized. The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT OCLN peptide-treated transfectants. (E) After the BEAS-2b cells were harvested, cell lysates were used for MTT assay. (F) After mitochondria from the cells was isolated, the mitochondria lysates were used for mtROS measurement. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS only; ∗∗∗ p < 0.05 compared with LPS- and WT occludin peptide-treated cells. All data shown are representative of three independent experiments.
Techniques Used: Activation Assay, Mutagenesis, Incubation, Western Blot, Control, Transfection, Over Expression, Construct, Negative Control, Quantitative RT-PCR, Membrane, Staining, Fluorescence, MTT Assay, Isolation
Related Articles
Sterility:Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia. Article Snippet: Blasts were then cultured at 1 × 106 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia Article Snippet: Blasts were then cultured at 1 × 10 6 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant Recombinant:Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia. Article Snippet: Blasts were then cultured at 1 × 106 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant Article Title: Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease. Article Snippet: Patients with chronic kidney disease (CKD) are at a significantly increased risk of stroke and experience worse stroke outcomes and higher mortality.. CKD exacerbates stroke risk and severity through a complex interplay of systemic inflammation, oxidative stress, and impaired clearance of uremic toxins, leading to neuroinflammation and microglial activation.. Current acute ischemic stroke treatments, while effective in the general population, do not adequately address CKD-specific mechanisms, limiting their efficacy in this high-risk population. Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia Article Snippet: Blasts were then cultured at 1 × 10 6 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant Article Title: Type I Interferon Signaling is Required for Oncostatin-M Driven Inflammatory Responses in Mouse Lung. Article Snippet: Type I interferons (IFNs) consist of a group of structurally similar cytokines that play an integral role in regulating the immune response to combat lung infections.. In certain models type I IFNs have also been associated with suppression of Th2-skewed immune and inflammatory responses.. Transient pulmonary overexpression of the gp130 cytokine Oncostatin M (OSM) by Adenovirus vector (AdOSM) induces a robust Th2-skewed cytokine/inflammatory profile in C57Bl/6 murine lungs. Article Title: A Transient Immunostimulatory Niche Synergizes Adoptive and Endogenous Immunity for Enhanced Tumor Control Article Snippet: .. Article Title: Interleukin-7 and interleukin-15 drive CD4 + CD28 null T lymphocyte expansion and function in patients with acute coronary syndrome Article Snippet: CD4 + T cells were cultured at 2×10 5 cells per well in U-bottom 96-well plates in RPMI1640 (Life Technologies) containing 100 U/mL penicillin, 100 μg/mL streptomycin, and 15 mM l -glutamine (Sigma-Aldrich), supplemented with 5% pooled human AB serum (Corning). .. Cells were stimulated with the indicated concentrations of recombinant Article Title: Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway Article Snippet: X-vivo 15 medium and the human T cell nucleofector kit were from Lonza technologies (Basel, PMA, ionomycin, collagenase IV, ROCK inhibitor (Y27632) and the general MMP inhibitor (GM6001) were from Sigma-Aldrich (St. Louis, MO). .. Article Title: Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications. Article Snippet: PBMC were washed twice in PBS, and plated in 96-well flat bottom plates at the density of 5 × 105 cells/well in RPMI 1640 (Sigma) supplemented with 10% fetal bovine serum (Gibco), 1% penicillin, and streptomycin. .. Stimulations with recombinant Cell Culture:Article Title: Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease. Article Snippet: Patients with chronic kidney disease (CKD) are at a significantly increased risk of stroke and experience worse stroke outcomes and higher mortality.. CKD exacerbates stroke risk and severity through a complex interplay of systemic inflammation, oxidative stress, and impaired clearance of uremic toxins, leading to neuroinflammation and microglial activation.. Current acute ischemic stroke treatments, while effective in the general population, do not adequately address CKD-specific mechanisms, limiting their efficacy in this high-risk population. Article Title: Interleukin-7 and interleukin-15 drive CD4 + CD28 null T lymphocyte expansion and function in patients with acute coronary syndrome Article Snippet: CD4 + T cells were cultured at 2×10 5 cells per well in U-bottom 96-well plates in RPMI1640 (Life Technologies) containing 100 U/mL penicillin, 100 μg/mL streptomycin, and 15 mM l -glutamine (Sigma-Aldrich), supplemented with 5% pooled human AB serum (Corning). .. Cells were stimulated with the indicated concentrations of recombinant Blocking Assay:Article Title: Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway Article Snippet: X-vivo 15 medium and the human T cell nucleofector kit were from Lonza technologies (Basel, PMA, ionomycin, collagenase IV, ROCK inhibitor (Y27632) and the general MMP inhibitor (GM6001) were from Sigma-Aldrich (St. Louis, MO). .. Control:Article Title: Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway Article Snippet: X-vivo 15 medium and the human T cell nucleofector kit were from Lonza technologies (Basel, PMA, ionomycin, collagenase IV, ROCK inhibitor (Y27632) and the general MMP inhibitor (GM6001) were from Sigma-Aldrich (St. Louis, MO). .. |
